Cargando…
Robenacoxib in the treatment of pain in cats and dogs: safety, efficacy, and place in therapy
Robenacoxib is a novel nonsteroidal anti-inflammatory drug (NSAID) of coxib class developed for the control of inflammation and pain in dogs and cats. It shows high selectivity for the cyclooxygenase-2 (COX-2) enzyme in rats, cats, and dogs. Robenacoxib is available in both injectable and tablet for...
Autores principales: | Kongara, Kavitha, Chambers, John Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101027/ https://www.ncbi.nlm.nih.gov/pubmed/30148083 http://dx.doi.org/10.2147/VMRR.S170893 |
Ejemplares similares
-
Efficacy and Safety of Injectable Robenacoxib for the Treatment of Pain Associated With Soft Tissue Surgery in Dogs
por: Friton, G., et al.
Publicado: (2017) -
Clinical safety of robenacoxib in cats with chronic musculoskeletal disease
por: King, Jonathan N., et al.
Publicado: (2021) -
Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs
por: Friton, Gabriele, et al.
Publicado: (2017) -
Comparison of post-operative analgesic efficacy of tolfenamic acid and
robenacoxib in ovariohysterectomized cats
por: SATTASATHUCHANA, Panpicha, et al.
Publicado: (2018) -
Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib
por: Lees, Peter, et al.
Publicado: (2022)